Omega-3 Polyunsaturated Fatty Acids in Treatment of Patients with Coronary Heart Disease and Type 2 Diabetes Mellitus

Omega-3 Polyunsaturated Fatty Acids in Treatment of Patients with Coronary Heart Disease and Type 2 Diabetes Mellitus

Increased platelet aggregation is one of the major risk factors for cardiovascular events. However, recent studies have demonstrated the inhibition of platelet aggregation by omega-3 PUFAs. The aim of this work was to study the effect of the addition of omega-3 PUFAs to the combination of aspirin an...

Full description

Bibliographic Details
Main Authors:	Aisulu T. Mussagalieva, MD, PhD, Gulnara M. Imantaeva, MD, PhD
Format:	Article
Language:	English
Published:	International Medical Research and Development Corporation 2012-03-01
Series:	International Journal of Biomedicine
Subjects:	coronary heart disease type 2 diabetes mellitus platelet aggregation treatment.
Online Access:	http://www.ijbm.org/articles/2_1_CR4.pdf

Similar Items

Effect of hyperglycemia on acute coronary syndrome and the implications of antiplatelet therapy
by: Pérez Bedoya, Juan Pablo, et al.
Published: (2019-04-01)

A Spleen Complication After an Acute Myocardial Infarction
by: Diana de Campos, MD, et al.
Published: (2020-04-01)

Increased platelet reactivity and platelet–leukocyte aggregation after elective coronary bypass surgery
by: Torbjörn Ivert, et al.
Published: (2019-11-01)

Effect of pretreatment with omega-3 polyunsaturated fatty acids (PUFAs) on hematological parameters and platelets aggregation in patients during elective coronary artery bypass grafting
by: Veljović Milić, et al.
Published: (2013-01-01)

Antithrombotic therapy after X-ray endovascular treatment: Are there specific features in patients with diabetes mellitus?
by: I Z Bondarenko, et al.
Published: (2014-10-01)

The Search for New Prognosis Markers for Coronary Artery Disease
by: Filipe Welson Leal Pereira, et al.

Which Stent for Diabetic Patient With Coronary Artery Disease?∗
by: Myeong-Ki Hong, MD, PhD, et al.
Published: (2021-09-01)

White Clot Formation at Acetylcholine Testing
by: Paolo Angelini, MD, et al.
Published: (2021-05-01)

EFFECTS OF ANTIPLATELET TREATMENT ON THROMBOCYTIC AGGREGATING ABILITY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND IN COMBINATION WITH TYPE 2 DIABETES
by: Olena Karpenko
Published: (2019-04-01)

Vitamin D diminishes the high platelet aggregation of type 2 diabetes mellitus patients
by: Maya Sultan, et al.
Published: (2019-01-01)

Effect of indobufen vs. aspirin on platelet accumulation in patients with stable coronary heart disease after percutaneous coronary intervention: An open-label crossover study
by: Qiu-Ping Shi, et al.
Published: (2022-08-01)

Thrombopoietin and platelet aggregation in patients with stable coronary artery disease
by: Sanne Bøjet Larsen, et al.
Published: (2017-11-01)

Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention: How Short Is Too Short?
by: Philipp Mourikis, et al.
Published: (2023-01-01)

Interventional cardiology and diabetes mellitus: age of effective coronary heart disease treatment
by: Victor Yur'evich Kalashnikov, et al.
Published: (2011-03-01)

Early clinical outcomes of surgical myocardial revascularization in patients with preoperative platelet dysfunction
by: Stojiljković Vladimir, et al.
Published: (2023-01-01)

Effects of Omega-3 Polyunsaturated Fatty Acids and Their Metabolites on Haemostasis—Current Perspectives in Cardiovascular Disease
by: Jacek Golanski, et al.
Published: (2021-02-01)

Platelet function, coagulation and fibrinolysis in patients with previous coronary and cerebrovascular ischemic events
by: Carlos José Dornas Gonçalves Barbosa, et al.

Unusual Case of Giant Nonthrombosed Right Coronary Artery Pseudoaneurysm With Coronary Artery Fistula
by: Yoshito Ito, MD, et al.
Published: (2021-05-01)

Recovery of platelet reactivity following cessation of either aspirin or ticagrelor in patients treated with dual antiplatelet therapy following percutaneous coronary intervention: a GLOBAL LEADERS substudy
by: Barry W. Hennigan, et al.
Published: (2022-01-01)

Factors influencing platelet aggregation in patients with acute coronary syndrome
by: A V Mazurov, et al.
Published: (2014-09-01)

Platelet Distribution Width on Admission Predicts In-Stent Restenosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Treated with Percutaneous Coronary Intervention
by: Cheng-Ping Hu, et al.
Published: (2018-01-01)

Association of human platelet alloantigens encoding gene polymorphisms with the risk of Coronary artery disease in Iranian patients
by: Farideh Malakootikhah, et al.
Published: (2021-02-01)

Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor Versus Clopidogrel in Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Coronary Intervention
by: Joseph M. Sweeny, et al.
Published: (2017-04-01)

Optimization of antiaggregant therapy in rheumatoid arthritis and coronary heart disease patients receiving nonsteroidal anti-inflammatory drugs
by: Tatyana Vladimirovna Kropotina, et al.
Published: (2012-08-01)

EFFECTS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS ON THE CIRCADIAN RHYTHM OF HEART RATE VARIABILITY PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CARDIOVASCULAR AUTONOMIC NEUROPATHY
by: V. A. Serhiyenko, et al.
Published: (2018-06-01)

Acute stent thrombosis in myocardial infarction complicated by cardiogenic shock in the presence of type 2 diabetes mellitus
by: Yu.H. Kyyak, et al.
Published: (2018-11-01)

Purposeful Review to Identify the Benefits, Mechanism of Action and Practical Considerations of Omega-3 Polyunsaturated Fatty Acid Supplementation for the Management of Diabetes Mellitus
by: Abdissa D
Published: (2021-03-01)

Diabetes mellitus, platelet function and acetylsalicylic acid
by: G.F. Gendeleka, et al.
Published: (2021-05-01)

Prevalência de alta reatividade plaquetária em pacientes tratados com aspirina encaminhados para angiografia coronária
by: André Manica, et al.

Myocardial protection during elective coronary artery bypasses grafting by pretreatment with omega-3 polyunsaturated fatty acids
by: Veljović Milić, et al.
Published: (2013-01-01)

Aggregation activity of blood formed elements in patients with type 1 and type 2 diabetes mellitus
by: Boris Il'ich Kuznik, et al.
Published: (2012-06-01)

Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome
by: Charlotte Grosdidier, et al.
Published: (2019-10-01)

OMEGA-3 POLYUNSATURATED FATTY ACIDS IN ATRIAL FIBRILLATION PREVENTION AFTER SURGICAL MYOCARDIAL REVASCULARIZATION
by: A. V. Panov, et al.
Published: (2016-01-01)

Platelet aggregability and anticoagulant proteins activity during dobutamine stress echocardiography in asymptomatic patients four months after percutaneous coronary intervention
by: Jović Zoran, et al.
Published: (2019-01-01)

Acute coronary syndrome in a young patient with ECG presentation of acute inferior myocardial infarction and acute thrombosis of left main stem coronary artery
by: Đenić Nemanja, et al.
Published: (2023-01-01)

Variations in the Gene Expression Profile in Atherosclerotic Patients with Non-Fatal ACS: A Preliminary Study
by: Angela Dziedzic, et al.
Published: (2022-04-01)

The role of antiaggregant agents and anticoagulants in the prevention of aortic valve endocarditis: A double-cohort retrospective studyCentral MessagePerspective
by: Hanne Theys, MD, et al.
Published: (2021-12-01)

ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION
by: D. H. Ainetdinova, et al.
Published: (2016-01-01)

Association of ITGB3, P2RY12, and CYP2C19 gene polymorphisms with platelet functional activity in patients with coronary heart disease during dual antiplatelet therapy
by: E F Muslimova, et al.
Published: (2017-05-01)

Comparative analysis of biochemical parameters of atherosclerosis adiponectin and resistin in patients with diabetes mellitus and coronary heart disease
by: Rašić D., et al.
Published: (2015-01-01)